Samsara Biocapital
$1.0B Assets Reported
24 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 6,897,652 | $339M | 32.9% |
| MLYS | MINERALYS THERAPEUTICS INC | 5,871,018 | $159M | 15.5% |
| ALMS | ALUMIS INC | 6,345,219 | $140M | 13.6% |
| SEPN | SEPTERNA INC | 3,149,128 | $76M | 7.4% |
| KLRS | KALARIS THERAPEUTICS INC | 12,948,081 | $75M | 7.3% |
| SGP | SPYGLASS PHARMA INC | 2,109,953 | $55M | 5.3% |
| NGNE | NEUROGENE INC | 1,717,127 | $35M | 3.4% |
| IVA | INVENTIVA SA | 5,194,805 | $29M | 2.8% |
| STRO | SUTRO BIOPHARMA INC | 1,062,872 | $26M | 2.6% |
| JBIO | JADE BIOSCIENCES INC | 968,798 | $14M | 1.3% |
Track Samsara Biocapital's 13F portfolio: $1.0B in reported holdings, 24 positions. Top holdings, AUM, and quarterly changes on SentiSense.